Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways - PubMed (original) (raw)
. 1997 Sep 4;15(10):1219-32.
doi: 10.1038/sj.onc.1201273.
Affiliations
- PMID: 9294616
- DOI: 10.1038/sj.onc.1201273
Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways
G Packham et al. Oncogene. 1997.
Abstract
Enforced c-Myc expression promotes continuous, growth factor-independent, cell cycle progression and activates expression of the ornithine decarboxylase (ODC) gene and its promoter. c-Myc-responsiveness of murine ODC is mediated by two conserved c-Myc:Max E-boxes in ODC intron 1. c-Myc and ODC are both required for cell growth and their expression is sequentially induced in G0/G1 cells stimulated with mitogens, yet their expression is not modulated by the cell cycle in proliferating cells. Here we demonstrate that regulation of ODC and its promoter by Interleukin-3 (IL-3) in murine myeloid cells is mediated in part by c-Myc, c-Myc induced ODC through the same transcription start site as IL-3 and, in asynchronously growing cells, maximal activity of the ODC promoter required the intronic c-Myc binding sites. However, induction of ODC following IL-3 stimulation of quiescent cells is mediated by at least two pathways. The first phase of this response was independent of the intronic c-Myc:Max E-boxes and de novo protein synthesis. Sustained induction of the ODC promoter however required the c-Myc:Max binding sites and protein synthesis. Accumulation of c-Myc following stimulation of quiescent cells with IL-3 correlated with the delayed phase of the response. Consistent with a two pathway model of ODC regulation, inducible overexpression of dominant negative form of c-Myc (In373-Myc), which specifically inhibits the c-Myc-Max network, inhibited the delayed, but not immediate, induction of ODC promoter activity in response to IL-3. Dominant negative c-Myc protein also effectively suppressed induction of the endogenous ODC gene by IL-3. Therefore, c-Myc functions as a direct and required-regulator of ODC. These results also suggest a model whereby c-Myc's role in regulating its targets may be to convert a transient, immediate-early, activation event into the persistent induction of gene expression.
Similar articles
- Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
Peña A, Wu S, Hickok NJ, Soprano DR, Soprano KJ. Peña A, et al. J Cell Physiol. 1995 Feb;162(2):234-45. doi: 10.1002/jcp.1041620209. J Cell Physiol. 1995. PMID: 7822433 - Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells.
Farrar WL, Willette-Brown J, Linnekin D. Farrar WL, et al. Lymphokine Cytokine Res. 1991 Aug;10(4):291-9. Lymphokine Cytokine Res. 1991. PMID: 1718453 - WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth.
Soprano KJ. Soprano KJ. J Cell Biochem. 1994 Apr;54(4):405-14. doi: 10.1002/jcb.240540407. J Cell Biochem. 1994. PMID: 8014189 Review. - The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. Hoffman B, et al. Oncogene. 2002 May 13;21(21):3414-21. doi: 10.1038/sj.onc.1205400. Oncogene. 2002. PMID: 12032779 Review.
Cited by
- Polyamine Metabolism as a Therapeutic Target inHedgehog-Driven Basal Cell Carcinomaand Medulloblastoma.
Coni S, Di Magno L, Serrao SM, Kanamori Y, Agostinelli E, Canettieri G. Coni S, et al. Cells. 2019 Feb 11;8(2):150. doi: 10.3390/cells8020150. Cells. 2019. PMID: 30754726 Free PMC article. Review. - Ancillary Activity: Beyond Core Metabolism in Immune Cells.
Puleston DJ, Villa M, Pearce EL. Puleston DJ, et al. Cell Metab. 2017 Jul 5;26(1):131-141. doi: 10.1016/j.cmet.2017.06.019. Cell Metab. 2017. PMID: 28683280 Free PMC article. Review. - CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.
Amelio AL, Fallahi M, Schaub FX, Zhang M, Lawani MB, Alperstein AS, Southern MR, Young BM, Wu L, Zajac-Kaye M, Kaye FJ, Cleveland JL, Conkright MD. Amelio AL, et al. Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3260-8. doi: 10.1073/pnas.1319176111. Epub 2014 Jul 28. Proc Natl Acad Sci U S A. 2014. PMID: 25071166 Free PMC article. - Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
Tago K, Funakoshi-Tago M, Itoh H, Furukawa Y, Kikuchi J, Kato T, Suzuki K, Yanagisawa K. Tago K, et al. Oncogene. 2015 Jan 15;34(3):314-22. doi: 10.1038/onc.2013.561. Epub 2014 Jan 27. Oncogene. 2015. PMID: 24469041 - Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development.
Dorfman MD, Kerr B, Garcia-Rudaz C, Paredes AH, Dissen GA, Ojeda SR. Dorfman MD, et al. Endocrinology. 2011 Dec;152(12):5005-16. doi: 10.1210/en.2011-1465. Epub 2011 Oct 25. Endocrinology. 2011. PMID: 22028443 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials